Managing Adverse Effects of Incretin-Based Medications for Obesity
Robert F. Kushner, Jaime P. Almandoz, Domenica Rubino
Abstract
This JAMA Insights explores optimal strategies for managing the adverse effects associated with incretin-based medications for obesity, including semaglutide and tirzepatide.
Topics & Concepts
MedicineSemaglutideIncretinAdverse effectObesityIntensive care medicineExenatideDiabetes mellitusType 2 diabetesInternal medicineEndocrinologyLiraglutidePharmacology and Obesity TreatmentDiabetes Treatment and ManagementLipoproteins and Cardiovascular Health